(AASLD) The Liver Meeting® 2026 - Poster Presentation
Nov 07, 2026 at 1:00 PM MST
Session: MASLD/MASH Therapeutics
Abstract Title: Gastrointestinal Tolerability of Pemvidutide Without Dose Titration in Patients with Metabolic Dysfunction-Associated Steatohepatitis from the Phase 2b IMPACT Trial
Speaker: Dr. Mazen Noureddin
